Key facts
- It has raised $250K; the latest was Accelerator/Incubator ($100K) in Oct 2025.
- Notable investors include Right Side Capital Management, Forum Ventures.
- Status: Privately Held (backing).
- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Optio.ai
- ·The full record, as it builds
Funding rounds
No funding rounds for Optio.ai are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Optio.ai
Operator of healthcare execution infrastructure intended for post-prescription management. The company's platform integrates prescription access, patient engagement, and fulfillment into a unified workflow through intelligent scheduling, real-time communication, digital copays, cold-chain compliance, and end-to-end visibility, enabling health systems and pharmacies to improve access, reduce leakage, support adherence, and drive clinical and financial outcomes.
- Sector
- Healthcare
- HQ
- New York, NY, United States
- Founded
- 2024
- Website
- optiodelivers.com/
- Ownership
- Privately Held (backing)
Optio.ai doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Optio.ai shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Optio.ai in its N-PORT filings yet. We sweep new filings monthly.